The content is available as a PDF (1.6 MB).
. 2022 Jun 16;162(7):S-599–S-600. doi: 10.1016/S0016-5085(22)61416-1
Su1494: REDUCED SEROLOGICAL RESPONSE TO COVID-19 VACCINES IN PATIENTS WITH IBD IS FURTHER DIMINISHED BY TNF INHIBITOR THERAPY; EARLY RESULTS OF THE VARIATION STUDY (VARIABILITY IN RESPONSE IN IBD AGAINST SARS-COV2-IMMUNISATION)
Jayne Doherty
, Roisin Stack
, Neil O'Morain
, Parker Girod
, Miriam Tosetto
, Rosanna Inzitari
, Juliette Sheridan
, Garret Cullen
, Maire Buckley
, Hugh E Mulcahy
, Elizabeth J Ryan
, David J Daghfal
, Peter Doran
, Colm A O'Morain
, Glen Doherty
Jayne Doherty
Find articles by Jayne Doherty
Roisin Stack
Find articles by Roisin Stack
Neil O'Morain
Find articles by Neil O'Morain
Parker Girod
Find articles by Parker Girod
Miriam Tosetto
Find articles by Miriam Tosetto
Rosanna Inzitari
Find articles by Rosanna Inzitari
Juliette Sheridan
Find articles by Juliette Sheridan
Garret Cullen
Find articles by Garret Cullen
Maire Buckley
Find articles by Maire Buckley
Hugh E Mulcahy
Find articles by Hugh E Mulcahy
Elizabeth J Ryan
Find articles by Elizabeth J Ryan
David J Daghfal
Find articles by David J Daghfal
Peter Doran
Find articles by Peter Doran
Colm A O'Morain
Find articles by Colm A O'Morain
Glen Doherty
Find articles by Glen Doherty
Issue date 2022 May.
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9212484